TP53 and esophageal squamous cell carcinoma: Therefore, it is paramount to target the p53 gene for treating esophageal cancer and to find new small-molecule compounds that restore the function of mutp53, which may lay the foundation for establishing targeted therapy for patients with ESCC expressing mutp53.